Haplotype and mutation analysis of the TGFBR3 gene in Chinese women with idiopathic premature ovarian failure

References

• Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris) 2003;64:87–92.
   PubMed Web of Science ®Google Scholar
• Timmreck LS, Reindollar RH. Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am 2003;30:287–302.
   PubMed Web of Science ®Google Scholar
• Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604–606.
   PubMed Web of Science ®Google Scholar
• Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996;65:337–341.
   PubMed Web of Science ®Google Scholar
• Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis 2006;1:9.
   PubMed Web of Science ®Google Scholar
• Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000;404:411–414.
   PubMed Web of Science ®Google Scholar
• López-Casillas F, Wrana JL, Massagué J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 1993;73:1435–1444.
   PubMed Web of Science ®Google Scholar
• Ethier JF, Farnworth PG, Findlay JK, Ooi GT. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan. Mol Endocrinol 2002;16:2754–2763.
   PubMedGoogle Scholar
• Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, Okadome T, Miyazono K, López-Casillas F. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J Biol Chem 2001;276:14588–14596.
   PubMed Web of Science ®Google Scholar
• Wiater E, Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. J Biol Chem 2003;278:7934–7941.
   PubMed Web of Science ®Google Scholar
• Dixit H, Deendayal M, Singh L. Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 2004;19:1760–1764.
   PubMed Web of Science ®Google Scholar
• Dixit H, Rao KL, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty BN, Singh L. Mutational analysis of the betaglycan gene-coding region in susceptibility for ovarian failure. Hum Reprod 2006;21:2041–2046.
   PubMed Web of Science ®Google Scholar
• Prakash GJ, Kanth VV, Shelling AN, Rozati R, Sujatha M. Absence of 566C>T mutation in exon 7 of the FSHR gene in Indian women with premature ovarian failure. Int J Gynaecol Obstet 2009;105:265–266.
   PubMed Web of Science ®Google Scholar
• Zintzaras E. Inhibin alpha gene and susceptibility to premature ovarian failure: a data synthesis. Mol Hum Reprod 2009;15:551–555.
   PubMed Web of Science ®Google Scholar
• Hempel N, How T, Cooper SJ, Green TR, Dong M, Copland JA, Wood CG, Blobe GC. Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta. Carcinogenesis 2008;29:905–912.
   PubMed Web of Science ®Google Scholar
• Gatza CE, Oh SY, Blobe GC. Roles for the type III TGF-beta receptor in human cancer. Cell Signal 2010;22:1163–1174.
   PubMed Web of Science ®Google Scholar
• Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, Milsom SR, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000;15:2644–2649.
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97–98.
   PubMed Web of Science ®Google Scholar
• Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM, Schneyer AL. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab 2005;90:5582–5587.
   PubMed Web of Science ®Google Scholar
• Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, Small C, et al. Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol 2003;23:4371–4385.
   PubMed Web of Science ®Google Scholar
• Morén A, Ichijo H, Miyazono K. Molecular cloning and characterization of the human and porcine transforming growth factor-beta type III receptors. Biochem Biophys Res Commun 1992;189:356–362.
   PubMed Web of Science ®Google Scholar